Sara Ekeblad

Summary

Affiliation: Uppsala University
Country: Sweden

Publications

  1. ncbi Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cancer Res 14:7798-803. 2008
  2. ncbi Prognostic relevance of survivin in pancreatic endocrine tumors
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden
    World J Surg 36:1411-8. 2012
  3. ncbi Co-expression of ghrelin and its receptor in pancreatic endocrine tumours
    Sara Ekeblad
    Department of Medical Sciences, University Hospitals, Uppsala, Sweden
    Clin Endocrinol (Oxf) 66:115-22. 2007
  4. ncbi Islet cell tumours
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, 75185 Uppsala, Sweden
    Adv Exp Med Biol 654:771-89. 2010
  5. ncbi Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays
    Peter Stalberg
    Department of Surgical Sciences, University Hospital, Uppsala, Sweden
    Surgery 140:921-9; discussion 929-31. 2006
  6. ncbi Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cancer Res 13:2986-91. 2007

Detail Information

Publications6

  1. ncbi Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cancer Res 14:7798-803. 2008
    ....
  2. ncbi Prognostic relevance of survivin in pancreatic endocrine tumors
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden
    World J Surg 36:1411-8. 2012
    ..The prognostic relevance of nuclear and cytoplasmic survivin expression in pancreatic endocrine tumors-controlled for the tumor Ki-67 index, World Health Organization classification, and TNM stage-was investigated...
  3. ncbi Co-expression of ghrelin and its receptor in pancreatic endocrine tumours
    Sara Ekeblad
    Department of Medical Sciences, University Hospitals, Uppsala, Sweden
    Clin Endocrinol (Oxf) 66:115-22. 2007
    ....
  4. ncbi Islet cell tumours
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, 75185 Uppsala, Sweden
    Adv Exp Med Biol 654:771-89. 2010
    ..Radiofrequency ablation is increasingly used for liver metastases, and a number of new chemotherapy drugs are being tested. Despite improvements in treatment, no clear improvement in survival has been demonstrated...
  5. ncbi Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays
    Peter Stalberg
    Department of Surgical Sciences, University Hospital, Uppsala, Sweden
    Surgery 140:921-9; discussion 929-31. 2006
    ..Data on downstream effects of MEN1 gene inactivation is scarce. In an effort to identify genes regulated by MEN1, we designed a silencing experiment in a human endocrine pancreatic tumor cell line (BON1)...
  6. ncbi Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors
    Sara Ekeblad
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cancer Res 13:2986-91. 2007
    ..A retrospective analysis of the toxicity and efficacy of temozolomide in advanced neuroendocrine tumors...